# A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting

> **NCT02364531** · — · COMPLETED · sponsor: **Janssen Inc.** · enrollment: 194 (actual)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **OTHER:** Abiraterone Acetate (ZYTIGA): Prostate Cancer Registry

## Key facts

- **NCT ID:** NCT02364531
- **Lead sponsor:** Janssen Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-30
- **Primary completion:** 2018-11-01
- **Final completion:** 2018-11-01
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2019-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02364531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02364531, "A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02364531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*